The invention is in the technical field of devices for treating blood vessel clots, and more particularly devices for removing clots that block a cerebral artery, which are equipped with a blood porous fragment guard that prevents fragments of material from lodging in the cerebral artery.
The medical arts have advanced rapidly in the area of stroke treatment. Until recently, only medicinal treatment could be offered. Then, stents capable of retrieving the clot material blocking a blood vessel in an ischemic stroke were developed. Now, if a patient is seen quickly after onset the clot material can be swiftly removed, thereby saving a great deal of brain function, that would otherwise be lost.
Still, many challenges remain, in the removal of a clot that blocks a cerebral artery. One of these challenges is the tendency of fragments of material to break off of the clot as it is being removed, flow in the direction of blood flow, and lodge anew in some narrow cerebral artery, causing a secondary stroke, which can be damaging.
Notably, different types of clots have varying physical properties. Clots that form in the cerebral arteries, through an accumulation of material tend to have the consistency of gelatin. Some clots, however, form from material that has been deposited over time in the atria of the heart, and then breaks off (sometimes as the result of heart surgery) and travels to the cerebral arteries. This material has a consistency more similar to that of peanut butter. Finally, there are clots caused by material deposited in the aorta that breaks off and travels to the cerebral arteries. This material is typically harder than the material from the other two types of clots.
The following embodiments and aspects thereof are described and illustrated in conjunction with systems, tools and methods which are meant to be exemplary and illustrative, not limiting in scope. In various embodiments, one or more of the above-described problems have been reduced or eliminated, while other embodiments are directed to other improvements.
In a first separate aspect, the present invention may take the form of a stent retriever assembly having a proximal end and a distal end and including a mesh tube having a distal and proximal end and being connected to a first wire. Also, a blood-porous fragment guard is at the distal end of the mesh tube and has a central hub and extends radially and proximally from the central hub. Further, a second wire is connected to the central hub, and when this second wire is pulled proximally relative to the first wire, the hub is pulled proximally, which thereby causes the fragment guard to deploy in expanded form.
In a second separate aspect, the present invention may take the form of a method of removing a clot from an artery, that utilizes a stent retriever assembly having a proximal end and a distal end. This stent retriever has a mesh tube having a distal and proximal end and being connected to a first wire and a blood-porous fragment guard at the distal end of the mesh tube. This fragment guard includes a central hub and extends radially and proximally from the central hub. Further, a second wire is connected to the central hub, and when this second wire is pulled proximally relative to the first wire, the hub is pulled proximally, which thereby causes the fragment guard to deploy in expanded form. In the method, the stent retriever is moved to a proximal side of the clot and is pushed through the clot. Then the second wire is pulled relative to the first wire, thereby widening the fragment guard and the stent retriever is pulled proximally to pull material from the clot proximally.
In a third separate aspect, the present invention may take the form of a stent retriever catheter assembly having a proximal end and a distal end, and including a catheter, having a flexible tube sized to fit through the arterial system of a person, and to reach a blood clot in an artery. A first and second wire extend through the tube and a handle is connected to the first and second wires, which can be advanced and retracted with at least 1 cm of independence relative to each other. Further, a mesh tube having a distal and proximal end is connected at its proximal end to the first wire. Finally, a blood-porous fragment guard is at the distal end of the mesh tube, includes a central hub, and extends radially and proximally from the central hub. When the second wire is connected to the central hub, and is pulled proximally relative to the first wire, the hub is pulled proximally, which thereby causes the fragment guard to deploy in expanded form.
In addition to the exemplary aspects and embodiments described above, further aspects and embodiments will become apparent by reference to the drawings and by study of the following detailed descriptions.
Exemplary embodiments are illustrated in referenced drawings. It is intended that the embodiments and figures disclosed herein are to be considered illustrative rather than restrictive.
Referring to
Referring also to
In one preferred embodiment, wire mesh 12 and spokes 24 are made of nitinol. In another preferred embodiment, mesh 12 and spokes 24 are made of a titanium alloy. In one embodiment, fabric 28 is made of woven strands of expanded polytetrafluoroethylene (ePTFE). In one embodiment, the weave is loose, to permit blood to flow through the interstices of the threads. In still another embodiment, the fabric 28 is made of threads arranged in a circular manner about said spokes, to form a pattern similar to that of a spider web.
Referring to
Referring to
The invention has industrial applicability in the field of manufacturing devices to aid surgeons in clearing a blood vessel of a clot.
While a number of exemplary aspects and embodiments have been discussed above, those possessed of skill in the art will recognize certain modifications, permutations, additions and sub-combinations thereof. It is therefore intended that the following appended claims and claims hereafter introduced are interpreted to include all such modifications, permutations, additions and sub-combinations as are within their true spirit and scope.
This application is a continuation-in-part of international application PCT/US17/61685, filed Nov. 15, 2017, which itself is a continuation of U.S. application Ser. No. 15/627,806, filed Jun. 20, 2017, now U.S. Pat. No. 9,848,906, issued Dec. 26, 2017, both of which are incorporated by reference as if fully set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
4762129 | Bonzel | Aug 1988 | A |
4794931 | Yock | Jan 1989 | A |
4932413 | Sbockey | Jun 1990 | A |
5160321 | Sahota | Nov 1992 | A |
5254088 | Lundquist et al. | Oct 1993 | A |
5509900 | Kirkman | Apr 1996 | A |
5571173 | Perodi | Nov 1996 | A |
5735289 | Pfeffer et al. | Apr 1998 | A |
5827324 | Cassell | Oct 1998 | A |
6010517 | Baccaro | Jan 2000 | A |
6059822 | Kenesaka et al. | May 2000 | A |
6142987 | Tsugita | Nov 2000 | A |
6283991 | Cox et al. | Sep 2001 | B1 |
6309399 | Barbut | Oct 2001 | B1 |
6344041 | Kupiecki et al. | Feb 2002 | B1 |
6371972 | Wallace et al. | Apr 2002 | B1 |
6391044 | Yadav et al. | May 2002 | B1 |
6540722 | Boyle | Apr 2003 | B1 |
6558405 | McInnes | May 2003 | B1 |
6652556 | Van Tassel et al. | Nov 2003 | B1 |
6695813 | Boyle | Feb 2004 | B1 |
6712766 | Harada | Mar 2004 | B2 |
6716237 | Alt | Apr 2004 | B1 |
7160318 | Greenberg et al. | Jan 2007 | B2 |
7195636 | Avellanet et al. | Mar 2007 | B2 |
7226475 | Lenz et al. | Jun 2007 | B2 |
7621928 | Thramann et al. | Nov 2009 | B2 |
7662168 | McGuckin et al. | Feb 2010 | B2 |
7927350 | Rabbitte | Apr 2011 | B2 |
8123796 | Kasprzak | Feb 2012 | B2 |
8512399 | Lafontaine | Aug 2013 | B2 |
8529614 | Berez et al. | Sep 2013 | B2 |
8545530 | Eskridge | Oct 2013 | B2 |
8551132 | Eskridge et al. | Oct 2013 | B2 |
8556930 | Ellingwood | Oct 2013 | B2 |
8668729 | Kaufmann et al. | Mar 2014 | B2 |
8734504 | Kelly | May 2014 | B2 |
8753362 | Widomski et al. | Jun 2014 | B2 |
8814925 | Hillaire | Aug 2014 | B2 |
8852205 | Brady | Oct 2014 | B2 |
8876863 | Eskridge | Nov 2014 | B2 |
8911490 | Perkins et al. | Dec 2014 | B2 |
9402708 | Holloway | Aug 2016 | B2 |
9456834 | Folk | Oct 2016 | B2 |
9463036 | Brady | Oct 2016 | B2 |
9848906 | Eskridge | Dec 2017 | B1 |
20020004667 | Adams | Jan 2002 | A1 |
20020013616 | Carter et al. | Jan 2002 | A1 |
20020022858 | Demond | Feb 2002 | A1 |
20020026211 | Khosravi | Feb 2002 | A1 |
20020042626 | Hanson | Apr 2002 | A1 |
20020072730 | McGill et al. | Jun 2002 | A1 |
20020103501 | Diaz | Aug 2002 | A1 |
20020107534 | Schaefer et al. | Aug 2002 | A1 |
20020138133 | Lenz et al. | Sep 2002 | A1 |
20020156457 | Fisher | Oct 2002 | A1 |
20020165576 | Boyle | Nov 2002 | A1 |
20020165601 | Clerc | Nov 2002 | A1 |
20030109917 | Rudin | Jun 2003 | A1 |
20030163158 | White | Aug 2003 | A1 |
20040034386 | Fulton et al. | Feb 2004 | A1 |
20040038460 | Scott | Feb 2004 | A1 |
20040122466 | Bales | Jun 2004 | A1 |
20040199197 | Eidenschink et al. | Oct 2004 | A1 |
20050060017 | Fischell et al. | Mar 2005 | A1 |
20050096735 | Hojeibane et al. | May 2005 | A1 |
20050283182 | Pierce et al. | Dec 2005 | A1 |
20060058834 | Do et al. | Mar 2006 | A1 |
20060106421 | Teoh | May 2006 | A1 |
20060135943 | Mandrusov et al. | Jun 2006 | A1 |
20060224179 | Kuharczyk et al. | Oct 2006 | A1 |
20060264905 | Eskridge et al. | Nov 2006 | A1 |
20060271154 | Woodall | Nov 2006 | A1 |
20060287668 | Fawzi | Dec 2006 | A1 |
20070088387 | Eskridge et al. | Apr 2007 | A1 |
20070191884 | Eskridge et al. | Aug 2007 | A1 |
20070299461 | Elliott | Dec 2007 | A1 |
20080004687 | Barbut et al. | Jan 2008 | A1 |
20080039929 | Davis et al. | Feb 2008 | A1 |
20080140051 | Bei | Jun 2008 | A1 |
20080243170 | Jenson et al. | Oct 2008 | A1 |
20090024157 | Anukhin | Jan 2009 | A1 |
20090082803 | Adams et al. | Mar 2009 | A1 |
20090132024 | Berkhoff | May 2009 | A1 |
20090171274 | Harlev et al. | Jul 2009 | A1 |
20090192405 | Carney | Jul 2009 | A1 |
20090292307 | Razack | Nov 2009 | A1 |
20090326640 | Yoshimura et al. | Dec 2009 | A1 |
20100042201 | Sherif | Feb 2010 | A1 |
20100057019 | Zelenka | Mar 2010 | A1 |
20100087850 | Razack | Apr 2010 | A1 |
20100087908 | Hilaire | Apr 2010 | A1 |
20100234878 | Hruska et al. | Sep 2010 | A1 |
20100280534 | Sher | Nov 2010 | A1 |
20110040314 | McGuckin, Jr. et al. | Feb 2011 | A1 |
20110040319 | Fulton, III | Feb 2011 | A1 |
20110046669 | Goraltchouk et al. | Feb 2011 | A1 |
20110112614 | Haarer | May 2011 | A1 |
20110118769 | Bliss et al. | May 2011 | A1 |
20110125181 | Brady | May 2011 | A1 |
20110137334 | Anderson et al. | Jun 2011 | A1 |
20110160833 | Gonzalez et al. | Jun 2011 | A1 |
20110190863 | Ostroot | Aug 2011 | A1 |
20110196414 | Porter | Aug 2011 | A1 |
20120046676 | Morsi | Feb 2012 | A1 |
20120053596 | Gordon | Mar 2012 | A1 |
20120071911 | Sadasivan et al. | Mar 2012 | A1 |
20120130408 | Shur et al. | May 2012 | A1 |
20130090682 | Bachman et al. | Apr 2013 | A1 |
20130197567 | Brady | Aug 2013 | A1 |
20130204290 | Clarke et al. | Aug 2013 | A1 |
20130345738 | Eskridge | Dec 2013 | A1 |
20140005651 | Eskridge | Jan 2014 | A1 |
20140074149 | Garcia et al. | Mar 2014 | A1 |
20140094896 | Berez et al. | Apr 2014 | A1 |
20140114342 | Berez et al. | Apr 2014 | A1 |
20140121672 | Folk | May 2014 | A1 |
20140172071 | Berez et al. | Jun 2014 | A1 |
20140296889 | Avneri | Oct 2014 | A1 |
20150173782 | Garrison | Jun 2015 | A1 |
20150313732 | Fulton, III | Nov 2015 | A1 |
20160022291 | Johnson | Jan 2016 | A1 |
20160120570 | Kobayashi | May 2016 | A1 |
20160206426 | Khoynezhad | Jul 2016 | A1 |
20170112513 | Marchand | Apr 2017 | A1 |
20170112514 | Marchand | Apr 2017 | A1 |
20170119408 | Ma | May 2017 | A1 |
20170128089 | Ma | May 2017 | A1 |
Number | Date | Country |
---|---|---|
1645242 | Apr 2006 | EP |
1955661 | Aug 2008 | EP |
2308383 | Jun 2014 | EP |
2407466 | Dec 2010 | RU |
9000371 | Jan 1990 | WO |
9825656 | Jun 1998 | WO |
9956801 | Nov 1999 | WO |
0128434 | Apr 2001 | WO |
0135839 | May 2001 | WO |
03099168 | Dec 2003 | WO |
2005037129 | Apr 2005 | WO |
2011106426 | Sep 2011 | WO |
2012120490 | Sep 2012 | WO |
2012167156 | Dec 2012 | WO |
2013109784 | Jul 2013 | WO |
2014047650 | Mar 2014 | WO |
2016049529 | Mar 2016 | WO |
Entry |
---|
Machi Paolo et al. Solitaire FR thrombectomy system: immediate results in 56 1-22 consecutive acute ischemic stroke patients. J Neurointervent Surg 2012; 4(1):pp. 62-66, procedure, fig. 1,2. |
International Search Report and Written Opinion issued by ISA Australia Patent Office dated Mar. 7, 2018 for related PCT international application PCT/US2017/061685. |
Number | Date | Country | |
---|---|---|---|
20200121355 A1 | Apr 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15627806 | Jun 2017 | US |
Child | PCT/US2017/061685 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2017/061685 | Nov 2017 | US |
Child | 16724065 | US |